ArticleJournal of gastrointestinal cancer2025

Clinical Efficacy and Safety of Apatinib Combined with Irinotecan in HER2-negative Patients with Advanced Gastric or Gastroesophageal Junction Adenocarcinoma after First-Line Treatment Failure: A Single-Arm, Single-Center Retrospective Study.

Jiajia Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.